Michael Scolaro

Michael Scolaro

Aug 27, 2017

Group 6 Copy 55
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Ebola video voice-over recording in 10 African local languages

    Ebola virus is spreading rapidly in West Africa. We are sharing a 3D animation explaining the symptoms of...

    MyHealthEd

    Each child deserves quality comprehensive sexual health education. No child is the same, so why...

    Improving the detection of expired medication in developing countries to improve maternal health

    Oxytocin prevents maternal mortality by reducing bleeding after giving birth. It's limited in rural areas...

    Backer Badge Funded